Pancreatic Ductal Adenocarcinoma
2 competing products in clinical development for Pancreatic Ductal Adenocarcinoma.
Pipeline by Phase
Phase 11
Phase 1/21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ASP2138 + Oxaliplatin + Leucovorin + 5-FU + Irinotecan + Gemcitabine + Nab-paclitaxel + Capecitabine | Astellas Pharma | Phase 1 | Recruiting | 36 |
| [203Pb]Pb-PSV359 + [212Pb]Pb-PSV359 | Perspective Therapeutics | Phase 1/2 | Recruiting | 33 |